| Literature DB >> 32684917 |
Claudia Munoz-Zanzi1, Emily Groene1, Bozena M Morawski1, Kimberly Bonner1, Federico Costa2, Eric Bertherat3, Maria Cristina Schneider4.
Abstract
OBJECTIVE: This review describes the geographic and temporal distribution of, detection methods for, and other epidemiological features of published leptospirosis outbreaks, with the aim of informing efforts to standardize outbreak-reporting practices.Entities:
Keywords: Leptospira; Leptospirosis; disease outbreaks; public health surveillance; zoonoses
Year: 2020 PMID: 32684917 PMCID: PMC7363284 DOI: 10.26633/RPSP.2020.78
Source DB: PubMed Journal: Rev Panam Salud Publica ISSN: 1020-4989
Assessment checklist to evaluate the quality of evidence for leptospirosis outbreak from a systematic literature review, 1970–2012
Quality criteria | Leptospirosis outbreak definition | Laboratory confirmation with standard methods and definitions [ | Case ascertainment whether community or hospital/provider-based | Time period | Number of outbreaks |
|---|---|---|---|---|---|
By author or at least two epidemiologically related cases | ... | ... | ... | 318 | |
By author or at least two epidemiologically related cases | Outbreak with at least one confirmed case or with probable cases only | ... | ... | 118 | |
By author or at least two epidemiologically related cases | Outbreak with at least one confirmed case | ... | ... | 127 | |
By author or at least two epidemiologically related cases | Outbreak with at least one confirmed case | ... | Defined duration reported | 86 | |
By author or at least two epidemiologically related cases | Outbreak with at least one confirmed case | Active ascertainment of cases whether communityor hospital/provider-based | Defined duration reported | 54 |
a Laboratory confirmed: four-fold increase in MAT titer between acute and convalescent samples, MAT titer =1:400 in single sample, positive for Leptospira by PCR, culture, or immunohistochemistry. Probable cases: positive for IgM, MAT titer =1:100 and <1:400 in single acute sample.
MAT: microagglutination test. PCR: polymerase chain reaction.
Prepared by authors from study-collected data.
FIGURE 1.Flow chart of a systematic literature review of leptospirosis outbreaks reported in scientific literature from 1970 to 2012
FIGURE 2.Global distribution of human leptospirosis outbreaks reported in the literature by ecoregion obtained from a systematic literature review from 1970 to 2012
FIGURE 3.Number of human leptospirosis outbreaks by setting obtained from a systematic review of literature between 1970 and 2012 (n = 306)a
Number and proportion of leptospirosis outbreaks obtained from a systematic literature review from 1970 to 2012 reporting specific clinical manifestations
| Outbreak age distributiona [ |
| |||
|---|---|---|---|---|---|
Clinical presentation (number of outbreaks) | Children only ( | Adults only ( | Both ( | Undetermined ( | Total ( |
Fever | 12 (100%) | 31 (89%) | 32 (100%) | 20 (83%) | 95 (92%) |
Jaundice | 7 (58%) | 17 (49%) | 19 (59%) | 9 (38%) | 52 (50%) |
Renal injury | 3 (25%) | 17 (49%) | 18 (56%) | 8 (33%) | 46 (45%) |
Pulmonary injury | 3 (25%) | 3 (9%) | 11 (34%) | 9 (38%) | 26 (25%) |
Meningitis, neurological | 5 (42%) | 7 (20%) | 8 (25%) | 5 (21%) | 25 (24%) |
Stiff neck | 1 (8%) | 4 (11%) | 5 (16%) | 2 (8%) | 12 (12%) |
Uveitis, other eye symptoms | 3 (25%) | 3 (9%) | 3 (9%) | 2 (8%) | 11 (11%) |
Anorexia, weight loss | … | 7 (20%) | … | 2 (8%) | 9 (9%) |
Altered mental state | … | 2 (6%) | 4 (13%) | … | 6 (6%) |
Hepatitis, pancreatitis | 2 (17%) | … | … | 2 (8%) | 4 (4%) |
Myalgia, other pain | 1 (8%) | 1 (3%) | 1 (3%) | 1 (4%) | 4 (4%) |
a For a given age group, percentage is the proportion of outbreaks reporting occurrence of the specific clinical presentation (≥1 patient).
b n = 103, total outbreaks with ≥1 confirmed case and with clinical information in the report.
Prepared by authors from study-collected data.
Recommendation for leptospirosis outbreak reporting based on findings from a systematic literature review, 1970–2012
| Recommendations for reporting | Highlights from literature review |
|---|---|---|
Surveillance | • Describe surveillance type (passive, active) | 89% had as outbreak definition “increase in number of cases” |
| • Describe case ascertainment method (hospital-based, community-based) | 56% had specific dates |
| • State outbreak definition including population, location, and duration | 42% did not state case finding process |
Diagnostics | • State suspect, probable, and confirmed case definitions and case counts | 52% applied recognized case definitions |
| • State laboratory diagnostic effort with respect to number of cases | 40% stated at least one laboratory-confirmed case Increase in use of rapid tests without confirmation |
Outbreak characteristics | • Describe setting (urban, rural) and source | Location often identified as city instead of population affected |
| • Describe epidemic curve and outbreak type (point source, continuous common source) | 30% with undetermined source, no or broad risk factors |
| • Describe case demographic features |
|
| • Describe number of deaths, fatality ratio |
|
| • Describe clinical features of cases and deaths |
|
Outbreak response | • Describe type of outbreak investigation | 54% with outbreak investigation |
| • Describe identification of causal agent | 10% with outbreak response |
| • Describe outbreak response and timeline | 32% reported causative agent |
Prepared by authors from study-collected data.